ABT
ABBOTT LABORATORIES
NYSE · Healthcare · Medical - Devices · US
$105.25
−0.26%Price chart
Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 3Sep 9
ValuationView details →
P/E (Fwd)
18.2x
EV/EBITDA
21.1x
Market Cap
$182.12B
MomentumView details →
1D Return
−0.26%
YTD Return
−15.54%
RSI (14)
41.6
ValuationView details →
P/E (Fwd)
18.2x
EV/EBITDA
21.1x
Market Cap
$182.12B
RSI (14)
41.6
MomentumView details →
1D Return
−0.26%
YTD Return
−15.54%
SummaryUpdated Jun 1, 2026
Abbott Laboratories (NYSE:ABT) is a diversified healthcare company founded in 1888 and headquartered in North Chicago, Illinois. Originally established as a pharmaceutical company by Dr. Wallace Calvin Abbott, the company has evolved over more than 135 years into one of the world's largest healthcare corporations. Abbott operates across four major business segments: Medical Devices, Diagnostics, Nutritional Products, and Established Pharmaceutical Products, serving patients and healthcare providers in over 160 countries worldwide.
Similar companies
Latest newsMore news →
Abbott received FDA approval for its TactiFlex Duo catheter, expanding its atrial fibrillation ablation portfolio with dual PFA and RF energy options in the United States.11h agoAbbott launched Similac 360 Total Care Made With Whole Milk, the first and only ready-to-feed liquid infant formula made with whole milk in the U.S., at a price similar to its existing Similac powdered formula, available online and at major U.S. retailers.10d ago